Amsterdam, December 1, 2008 – EMBASE®, Elsevier’s biomedical and pharmaceutical abstract and indexing database, today announced that it has partnered with QUOSA™ to enable mutual customers to download and manage the full text of EMBASE.com search results via a newly established EMBASE.com channel in QUOSA Information Manager. QUOSA Information Manager boosts journal retrieval, search and management efficiency for individual users through post-search automated full article retrieval, article organization and specialized full-text searching. It has proven an indispensable tool for extracting key information from full text quickly and more easily, for example, kinetic parameters, microarray data, adverse events and toxicity data. In combination with QUOSA Virtual Library, the partnership enables expert searches on EMBASE.com to be integrated into an easy-to-use current awareness and literature access solution for larger groups.
Michael Rai, Director of Elsevier’s Pharmaceutical Development Group, comments, “The partnership between EMBASE.com and QUOSA opens up new possibilities and will no doubt help QUOSA users enhance their productivity and boost efficiency. It will now be much easier to navigate from the results of EMBASE.com searches to the full text, which is seen as one important step to integrate critical information into a user’s daily workflow.” EMBASE.com (http://www.info.embase.com) combines EMBASE and MEDLINE on one platform, providing users with timely and comprehensive access to pharmacological and biomedical literature. It contains records from over 7,000 journals published in more than 70 countries. Over 19 million bibliographic records are included with more than 2,000 new records added every working day. Users can navigate from citations to full text from the world’s leading scientific, technical and medical (STM} publishers.
“The integration of EMBASE.com as a channel for use with the QUOSA Information Manager and Virtual Library literature management application has been invaluable in our development of a Medical eLibrary Services group,” according to Amyas Huston, Senior Manager Medical Communications, Cubist Pharmaceuticals, Inc. “The combined functionality allows our group to conduct searches against both the EMBASE and MEDLINE bibliographic databases, retrieve selected articles and provide a literature document repository for copyright-compliant web-based access of publications to internal colleagues.”
Used extensively by the pharmaceutical industry, EMBASE.com retrieves information to support such tasks as: new drug development and discovery of new applications for existing drugs, drug safety and pharmacovigilance procedures, legislative and regulatory compliance, clinical trial program management, PI/Supplementary Protection Certificates and IB writing and regulatory filing documentation such as New Drug Applications (NDAs).
“We are very pleased to have added EMBASE.com to our supported channels, following on from our earlier support of Scopus,” says Malcolm MacKenzie, President of QUOSA. “EMBASE.com users can now benefit from the full power of our literature workflow solution, serving not only the information specialist’s own needs, but also providing superior current awareness and literature management for project teams and the wider organization.”
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.
Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier’s ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
About QUOSA
QUOSA Inc. is a specialist software company focused on supplying superior tools to life-science professionals for working with the scientific literature and research related documents. With a large and rapidly growing subscriber-base in academic and government research and medical centers and at leading pharmaceutical and biotechnology companies, QUOSA’s applications are used to compress time to insight across the key functions of the research endeavour. For more information about QUOSA, please visit: www.quosa.com.
